In this week’s issue of Mass High Tech, I’ve devoted my monthly column to the thinking behind “Power, Drugs and Money,” which will explore innovation in clean energy technology, life sciences and financial services. Some excerpts:
The selection of those three industries is conscious, and critical: They represent the past, present and future greatness of New England innovation. We have arguably been a world-class financial market for decades. More recently, we have evolved into a leading center of life sciences and biotechnology research and development. And the future bodes well for New England to have a substantial role in clean energy and environmental technologies.
But the conversation is not only about innovation in these three industries, but across them as well: New structures to finance energy projects. The changing face and economics of global clinical trials. Monetizing the carbon value chain. Biotechnology's impact on future fuel sources. Microentrepreneurship and new global lending models. Finding new ways to pay for health care delivery. The list goes on...
The vision is to create an environment for our community to gather, to have the conversation en masse and to work together to make 2008 the year when talk turns to action -- action focused on moving New England toward global greatness.
No comments:
Post a Comment